Evidence map›Paper›PMID 25584114›Full record

ArticleBiomicrofluidics2014

A microfluidic device to study cancer metastasis under chronic and intermittent hypoxia.

Miguel A Acosta, Xiao Jiang, Pin-Kang Huang, Kyle B Cutler, Christine S Grant, Glenn M Walker, Michael P Gamcsik

Abstract read
In one paragraph

Article in Biomicrofluidics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Breaking the mold: 3D cell cultures reshaping the future of cancer research.Frontiers in cell and developmental biology · 2024
    Review
  5. Article
  6. The Applications and Challenges of the Development ofCellular and molecular bioengineering · 2023
    Review
  7. Review
  8. Review
  9. Monitoring and modulation of the tumor microenvironment for enhanced cancer modeling.Experimental biology and medicine (Maywood, N.J.) · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Miguel A AcostaUNC/NCSU Joint Department of Biomedical Engineering, North Carolina State University , 4206D Engineering Building III, 911 Oval Drive, Raleigh, North Carolina 27695-7115, USA.
Xiao JiangUNC/NCSU Joint Department of Biomedical Engineering, North Carolina State University , 4206D Engineering Building III, 911 Oval Drive, Raleigh, North Carolina 27695-7115, USA.ORCID 0000-0001-8307-2170
Pin-Kang HuangDepartment of Chemical Engineering, National Taiwan University of Science and Technology , No. 43, Sec. 4, Keelung Road, Da'an District, Taipei City 106, Taiwan.
Kyle B CutlerDepartment of Biomedical Engineering, Beckman Laser Institute, University of California Irvine , 1002 Health Services Road, Irvine, California 92617, USA.ORCID 0000-0001-5735-8423
Christine S GrantUNC/NCSU Joint Department of Biomedical Engineering, North Carolina State University , 4206D Engineering Building III, 911 Oval Drive, Raleigh, North Carolina 27695-7115, USA.
Glenn M WalkerUNC/NCSU Joint Department of Biomedical Engineering, North Carolina State University , 4206D Engineering Building III, 911 Oval Drive, Raleigh, North Carolina 27695-7115, USA.
Michael P GamcsikDepartment of Chemical Engineering, National Taiwan University of Science and Technology , No. 43, Sec. 4, Keelung Road, Da'an District, Taipei City 106, Taiwan.

Funding

PDAC-on-a-Chip for Selection of Aggressive, Therapy-Resistant Tumor CellsR03CA167471 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI GAMCSIK, MICHAEL · 2012 to 2013
$145k
NCI NIH HHS R03 CA167471
6 · The paper itself

Abstract

Metastatic cancer cells must traverse a microenvironment ranging from extremely hypoxic, within the tumor, to highly oxygenated, within the host's vasculature. Tumor hypoxia can be further characterized by regions of both chronic and intermittent hypoxia. We present the design and characterization of a microfluidic device that can simultaneously mimic the oxygenation conditions observed within the tumor and model the cell migration and intravasation processes. This device can generate spatial oxygen gradients of chronic hypoxia and produce dynamically changing hypoxic microenvironments in long-term culture of cancer cells.

Identifiers

PMID25584114
PMCPMC4290574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.